1. Home
  2. IMRN vs YAAS Comparison

IMRN vs YAAS Comparison

Compare IMRN & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • YAAS
  • Stock Information
  • Founded
  • IMRN 1994
  • YAAS 2018
  • Country
  • IMRN Australia
  • YAAS China
  • Employees
  • IMRN N/A
  • YAAS N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • YAAS Computer Software: Prepackaged Software
  • Sector
  • IMRN Health Care
  • YAAS Technology
  • Exchange
  • IMRN Nasdaq
  • YAAS Nasdaq
  • Market Cap
  • IMRN 9.2M
  • YAAS 9.5M
  • IPO Year
  • IMRN N/A
  • YAAS 2024
  • Fundamental
  • Price
  • IMRN $1.86
  • YAAS $0.10
  • Analyst Decision
  • IMRN Strong Buy
  • YAAS
  • Analyst Count
  • IMRN 1
  • YAAS 0
  • Target Price
  • IMRN $5.00
  • YAAS N/A
  • AVG Volume (30 Days)
  • IMRN 55.1K
  • YAAS 4.9M
  • Earning Date
  • IMRN 08-29-2025
  • YAAS 07-14-2025
  • Dividend Yield
  • IMRN N/A
  • YAAS N/A
  • EPS Growth
  • IMRN N/A
  • YAAS N/A
  • EPS
  • IMRN N/A
  • YAAS N/A
  • Revenue
  • IMRN $4,777,422.00
  • YAAS $581,862.00
  • Revenue This Year
  • IMRN N/A
  • YAAS N/A
  • Revenue Next Year
  • IMRN N/A
  • YAAS N/A
  • P/E Ratio
  • IMRN N/A
  • YAAS N/A
  • Revenue Growth
  • IMRN 48.63
  • YAAS N/A
  • 52 Week Low
  • IMRN $1.50
  • YAAS $0.09
  • 52 Week High
  • IMRN $2.87
  • YAAS $7.00
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.87
  • YAAS 25.86
  • Support Level
  • IMRN $1.73
  • YAAS $0.30
  • Resistance Level
  • IMRN $1.89
  • YAAS $0.33
  • Average True Range (ATR)
  • IMRN 0.10
  • YAAS 0.03
  • MACD
  • IMRN 0.01
  • YAAS 0.02
  • Stochastic Oscillator
  • IMRN 76.77
  • YAAS 4.02

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About YAAS Youxin Technology Ltd Class A Ordinary shares

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: